Epic Code LAB1230929 HLA-B*57:01 Screen for Abacavir Hypersensitivity
Test Name Alias
CIB57, B57, ABACAVIR HYPERSENSITIVITY, HLA-B*5701 SCREENING
Clinical Information
The FDA recommends that genetic testing for HLA-B*5701 be performed prior to prescribing the reverse transcriptase inhibitor, Abacavir, to HIV patients. The presence of HLA-B*5701 is associated with a drug-induced hypersensitivity reaction to Abacavir that can be prevented with prior genetic screening.
Specimen Requirements
Specimen Collection: Blood
Container(s): 6 mL Pink Top (EDTA) or 3 mL Lavender Top (EDTA) or 8.5 mL Yellow Top ACD Tube
Preferred Volume to Collect: Full tube(s)
Collection Instructions:
- Gently invert EDTA tube(s) 8 - 10 times after collection.
Processing Instructions (Laboratory, Outpatient or Off-site collection)
- Processed Specimen: Whole Blood
- Centrifuge/Spin: No
- Aliquot: No
- Do not refrigerate or freeze specimen. Maintain whole blood at room temperature (20-26°C or 68-78.8°F) prior to transport. Transport to the Laboratory within 72 hours of collection.
- Transport: Ambient
Rejection Criteria
- Unlabeled specimens.
- Specimens drawn in clot, SST, or Heparin tubes.
- This test will only be performed once in a lifetime for a patient.
Specimen Stability
Specimen Stability for Testing:
Room Temperature (20-26°C or 68-78.8°F): 72 hours
Refrigerated (2-8°C or 36-46°F): Unacceptable
Frozen (-20°C/-4°F or below): Unacceptable
Specimen Storage in Department Prior to Disposal:
Frozen (-80°C): 2 years (DNA)
Test Frequency
Monday – Friday, 7:00 am – 5:00 pm.
Results available within 7 days.
Reference Range
Negative or positive for HLA-B*57:01.
Performing Department
Send Out to Corewell Health East
Performing Department Laboratory Location
Corewell Health Reference Laboratory East - Royal Oak HLA Laboratory
Methodology
Sequence Specific Priming (SSP) for HLA Class I Genotyping.
CPT
81381
CDM Code
81381
Epic Test ID
1230102990
LOINC
50956-2
Reviewed Date
Under review